ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Summit Therapeutics Inc

Summit Therapeutics Inc (SMMT)

14,555
-0,515
( -3,42% )
Mis à jour : 18:49:46

Summit Therapeutics Inc (SMMT) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
14,555
( -3,42% )
Prix Achat
14,55
Prix Vente
14,56
Volume échangé
2 096 572
14,5201 Fourchette du Jour 15,21
13,83 Plage de 52 semaines 30,98
Cap du marché
Clôture Veille
15,07
Ouverture
14,925
Dernière Transaction
40
@
14.5568
Dernière heure de transaction
18:49:50
Volume financier
US$ 30 816 231
VWAP
14,6984
Volume moyen (3 m)
US$ 3 943 225
Actions en circulation
776 162 645
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-9,86
Bénéfice par action (BPA)
-1,58
Chiffre d'affairess (LTM)
-
Bénéfice net (LTM)
-1,21B

À propos de Summit Therapeutics Inc

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1... Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Miami, United States
Fondé
2026
Summit Therapeutics Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker SMMT. Le dernier cours de clôture d'Summit Therapeutics était de US$15,07. Au cours de la dernière année, les actions de Summit Therapeutics ont été négociées dans une fourchette de prix de US$ 13,83 à US$ 30,98.

Summit Therapeutics compte actuellement 776 162 645 actions en circulation. La capitalisation boursière d'Summit Therapeutics est de US$11,30 milliard. Summit Therapeutics a un ratio cours/bénéfice (ratio PE) de -9.86.

Flux d'options Summit Therapeutics (SMMT)

Flux global

Haussier

Prime nette

365k

Calls / Puts

300,00%

Ach. / Vent.

700,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

SMMT Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-2.755-15.915655690417.3118.50514.17910425115.91379632DR
4-3.365-18.777901785717.9219.41514.17499044716.67160129DR
12-1.415-8.8603631809615.9729.2314.17425524118.62888523DR
26-3.735-20.420995079318.2929.2313.83336369717.78744605DR
52-5.545-27.587064676620.130.9813.83350244019.79018139DR
15612.785722.3163841811.7736.911.52306964016.27282203DR
2606.65584.24050632917.936.910.66262431412.24987453DR

SMMT - Frequently Asked Questions (FAQ)

What is the current Summit Therapeutics Inc share price?
The current share price of Summit Therapeutics Inc is US$ 14,555
How many Summit Therapeutics Inc shares are in issue?
Summit Therapeutics Inc has 776 162 645 shares in issue
What is the market cap of Summit Therapeutics Inc?
The market capitalisation of Summit Therapeutics Inc is USD 11,3B
What is the 1 year trading range for Summit Therapeutics Inc share price?
Summit Therapeutics Inc has traded in the range of US$ 13,83 to US$ 30,98 during the past year
What is the PE ratio of Summit Therapeutics Inc?
The price to earnings ratio of Summit Therapeutics Inc is -9,86
What is the registered address of Summit Therapeutics Inc?
The registered address for Summit Therapeutics Inc is 601 Brickell Key Drive, Miami, Florida, 33131
What is the Summit Therapeutics Inc website address?
The website address for Summit Therapeutics Inc is www.smmttx.com
Which industry sector does Summit Therapeutics Inc operate in?
Summit Therapeutics Inc operates in the Biotechnology & Life Sciences sector

SMMT Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées